VSee Health, Inc. Increase (Decrease) in Due from Related Parties
VSee Health, Inc. (VSEE) reported Increase (Decrease) in Due from Related Parties of -$227.04 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueFromRelatedParties · last filed 2026-03-31
- VSee Health, Inc. increase (decrease) in due from related parties for the quarter ending 2025-12-31 was $20.00K.
- VSee Health, Inc. increase (decrease) in due from related parties for the quarter ending 2025-09-30 was $43.49K.
- VSee Health, Inc. increase (decrease) in due from related parties for the quarter ending 2025-06-30 was -$48.03K.
- VSee Health, Inc. increase (decrease) in due from related parties for the quarter ending 2025-03-31 was -$242.50K.
- VSee Health, Inc. increase (decrease) in due from related parties for fiscal 2025 was -$227.04K.
- VSee Health, Inc. increase (decrease) in due from related parties for fiscal 2024 was -$254.38K.
| Period end | Increase (Decrease) in Due from Related Parties 3 month | Increase (Decrease) in Due from Related Parties 6 month | Increase (Decrease) in Due from Related Parties 9 month | Increase (Decrease) in Due from Related Parties 12 month |
|---|---|---|---|---|
| 2025-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $63.49K derived: sum of 2 quarters · filed 2026-03-31 | $15.46K derived: sum of 3 quarters · filed 2026-03-31 | -$227.04K 10-K · filed 2026-03-31 |
| 2025-09-30 | $43.49K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-11-14 | -$4.54K derived: sum of 2 quarters · filed 2025-11-20 | -$247.04K 10-Q · filed 2025-11-14 | -$275.77K derived: sum of 4 quarters · filed 2026-03-31 |
| 2025-06-30 | -$48.03K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2025-11-20 | -$290.53K 10-Q/A · filed 2025-11-20 | -$319.26K derived: sum of 3 quarters · filed 2026-03-31 | -$544.91K derived: sum of 4 quarters · filed 2026-03-31 |
| 2025-03-31 | -$242.50K 10-Q · filed 2025-10-15 | -$271.22K derived: sum of 2 quarters · filed 2026-03-31 | -$496.88K derived: sum of 3 quarters · filed 2026-03-31 | -$496.88K derived: sum of 4 quarters · filed 2026-03-31 |
| 2024-12-31 | -$28.72K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$254.38K derived: sum of 2 quarters · filed 2026-03-31 | -$254.38K derived: sum of 3 quarters · filed 2026-03-31 | -$254.38K 10-K · filed 2026-03-31 |
| 2024-09-30 | -$225.65K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-11-14 | -$225.65K derived: sum of 2 quarters · filed 2025-11-20 | -$225.65K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2025-11-20 | $0.00 10-Q/A · filed 2025-11-20 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |